Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-16-020170
Filing Date
2016-05-31
Accepted
2016-05-31 16:31:32
Documents
11
Period of Report
2016-06-27
Effectiveness Date
2016-05-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A srpt-def14a_20160627.htm DEF 14A 2600366
2 GRAPHIC gucfgrsy2pgu000007.jpg GRAPHIC 11295
3 GRAPHIC gucfgrsy2pgu000006.jpg GRAPHIC 14660
4 GRAPHIC gucfgrsy2pgu000001.jpg GRAPHIC 3818
5 GRAPHIC gucfgrsy2pgu000008.jpg GRAPHIC 2067
6 GRAPHIC gucfgrsy2pgu000009.jpg GRAPHIC 71313
7 GRAPHIC gucfgrsy2pgu000010.jpg GRAPHIC 51653
8 GRAPHIC gucfgrsy2pgu000002.jpg GRAPHIC 2521
9 GRAPHIC gucfgrsy2pgu000003.jpg GRAPHIC 3818
10 GRAPHIC gucfgrsy2pgu000004.jpg GRAPHIC 2184
11 GRAPHIC gucfgrsy2pgu000005.jpg GRAPHIC 3818
  Complete submission text file 0001564590-16-020170.txt   2833399
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14895 | Film No.: 161686282
SIC: 2834 Pharmaceutical Preparations